[{"idx": "16, 17", "type": "text", "classification": "synthesis condition", "content": "<title>Experimental Details</title><p>For materials, experimental details of synthesis of <italic toggle=\"yes\">N</italic>-(1-naphthyl)-2-pyrazinecarboxamide (ligand L1), and X-ray crystallography see .</p><p>Synthesis of [HgCl<sub>2</sub>(L1)<sub>2</sub>], <bold>1</bold>, [HgBr<sub>2</sub>(L1)], <bold>2</bold>, and [HgI<sub>2</sub>(L1)], <bold>3</bold>. To a solution of 0.2 mmol of mercuric (II) halide (HgX<sub>2</sub>, X = Cl, Br, and I) in 5 mL of methanol, a solution of 0.2 mmol of <italic toggle=\"yes\">N</italic>-(1-naphthyl)-2-pyrazinecarboxamide (ligand L1) in 5 mL of methanol was added with stirring. The mixture was heated at 313 K for about 10 min and then filtered. Upon slow evaporation of the filtrate at room temperature, colorless needle, colorless plate, and yellowish block crystals for [HgCl<sub>2</sub>(L1)<sub>2</sub>], [HgBr<sub>2</sub>(L1)], and [HgI<sub>2</sub>(L1)] complexes, respectively, suitable for X-ray analysis were obtained after several days (The ORTEP diagrams of asymmetric unit of <bold>1</bold>, <bold>2</bold> and <bold>3</bold> are shown in ). Yield ca. 63% for [HgCl<sub>2</sub>(L1)<sub>2</sub>] and 50% for [HgBr<sub>2</sub>(L1)] and 55% for [HgI<sub>2</sub>(L1)]. Melting points are 487 K for [HgCl<sub>2</sub>(L1)<sub>2</sub>] and about 418 K for [HgBr<sub>2</sub>(L1)] and 425 K for [HgI<sub>2</sub>(L1)]. It is notable that using 2:1 molar ratio of HgCl<sub>2</sub> to L1 ligand resulted in the same product of using 1:1 molar ratio.</p><p>Anal. Calcd for <bold>1</bold> (C<sub>30</sub>H<sub>22</sub>Cl<sub>2</sub>HgN<sub>6</sub>O<sub>2</sub>): C, 46.79; H, 2.88; N, 10.91. Found: C, 46.83; H, 2.81; N, 10.96. IR (CsI pellet, cm<sup>\u22121</sup>): 3363s, 3058, 1694s, 1545, 1501, 1408s, 1019s, 797s, 773s. <sup>1</sup>H NMR (DMSO, \u03b4 from TMS): 9.3867(s, 1H), 8.8850(d, 1H), 8.8232(d, 1H), 8.0282(m,1H), 7.9332(m,2H), 7.8329(m, 1H), 7.5628(m, 3H). <sup>13</sup>C NMR (DMSO, \u03b4 from TMS): 162.809 (C\ue5fbO), 148.285, 145.315, 144.382, 143.952, 143.151, 133.260, 128.740, 128.681, 126.752, 126.663 (two overlapped peak), 126.065, 123.032, 122.989. Anal. Calcd for <bold>2</bold> (C<sub>30</sub>H<sub>22</sub>Br<sub>4</sub>Hg<sub>2</sub>N<sub>6</sub>O<sub>2</sub>): C, 29.55; H, 1.82; N, 6.89. Found: C, 29.62; H, 1.89; N, 6.80. IR (CsI pellet, cm<sup>\u22121</sup>): 3359s, 3054, 1687, 1545, 1501s, 1397s, 1023s, 799s, 773s. <sup>1</sup>H NMR (DMSO, \u03b4 from TMS): 9.3876(s, 1H), 8.8851(d, 1H), 8.8209(d, 1H), 8.0279(m,1H), 7.9393(m,2H), 7.8320(m, 1H), 7.5519(m, 3H). <sup>13</sup>C NMR (DMSO, \u03b4 from TMS): 162.770 (C\ue5fbO), 148.226, 145.313, 144.337, 143.985, 143.131, 133.228, 128.717, 128.680, 126.756, 126.681 (two overlapped peak), 126.068, 123.022, 122.979. Anal. Calcd for <bold>3</bold> (C<sub>15</sub>H<sub>11</sub>I<sub>2</sub>HgN<sub>3</sub>O): C, 25.60; H, 1.58; N, 5.97. Found: C, 25.49; H, 1.62; N, 5.90. IR (CsI pellet, cm<sup>\u22121</sup>): 3336s, 3058, 1677, 1552, 1500s, 1409s, 1019s, 794s, 775s. <sup>1</sup>H NMR (DMSO, \u03b4 from TMS): 9.3916(s, 1H), 8.8838(d, 1H), 8.8264(d, 1H), 8.0323(m,1H), 7.9387(m,2H), 7.8347(m, 1H), 7.5504(m, 3H). <sup>13</sup>C NMR (DMSO, \u03b4 from TMS): 162.715 (C\ue5fbO), 148.193, 145.305, 144.318, 143.981, 143.121, 133.206, 128.689, 128.669, 126.731, 126.694 (two overlapped peak), 126.080, 122.940 (two overlapped peak).</p>", "clean_text": "Experimental Details\n\nFor materials, experimental details of synthesis of N-(1-naphthyl)-2-pyrazinecarboxamide (ligand L1), and X-ray crystallography see .\n\nSynthesis of [HgCl2(L1)2], 1, [HgBr2(L1)], 2, and [HgI2(L1)], 3. To a solution of 0.2 mmol of mercuric (II) halide (HgX2, X = Cl, Br, and I) in 5 mL of methanol, a solution of 0.2 mmol of N-(1-naphthyl)-2-pyrazinecarboxamide (ligand L1) in 5 mL of methanol was added with stirring. The mixture was heated at 313 K for about 10 min and then filtered. Upon slow evaporation of the filtrate at room temperature, colorless needle, colorless plate, and yellowish block crystals for [HgCl2(L1)2], [HgBr2(L1)], and [HgI2(L1)] complexes, respectively, suitable for X-ray analysis were obtained after several days (The ORTEP diagrams of asymmetric unit of 1, 2 and 3 are shown in ). Yield ca. 63% for [HgCl2(L1)2] and 50% for [HgBr2(L1)] and 55% for [HgI2(L1)]. Melting points are 487 K for [HgCl2(L1)2] and about 418 K for [HgBr2(L1)] and 425 K for [HgI2(L1)]. It is notable that using 2:1 molar ratio of HgCl2 to L1 ligand resulted in the same product of using 1:1 molar ratio.\n\nAnal. Calcd for 1 (C30H22Cl2HgN6O2): C, 46.79; H, 2.88; N, 10.91. Found: C, 46.83; H, 2.81; N, 10.96. IR (CsI pellet, cm-1): 3363s, 3058, 1694s, 1545, 1501, 1408s, 1019s, 797s, 773s. 1H NMR (DMSO, \u03b4 from TMS): 9.3867(s, 1H), 8.8850(d, 1H), 8.8232(d, 1H), 8.0282(m,1H), 7.9332(m,2H), 7.8329(m, 1H), 7.5628(m, 3H). 13C NMR (DMSO, \u03b4 from TMS): 162.809 (C\ue5fbO), 148.285, 145.315, 144.382, 143.952, 143.151, 133.260, 128.740, 128.681, 126.752, 126.663 (two overlapped peak), 126.065, 123.032, 122.989. Anal. Calcd for 2 (C30H22Br4Hg2N6O2): C, 29.55; H, 1.82; N, 6.89. Found: C, 29.62; H, 1.89; N, 6.80. IR (CsI pellet, cm-1): 3359s, 3054, 1687, 1545, 1501s, 1397s, 1023s, 799s, 773s. 1H NMR (DMSO, \u03b4 from TMS): 9.3876(s, 1H), 8.8851(d, 1H), 8.8209(d, 1H), 8.0279(m,1H), 7.9393(m,2H), 7.8320(m, 1H), 7.5519(m, 3H). 13C NMR (DMSO, \u03b4 from TMS): 162.770 (C\ue5fbO), 148.226, 145.313, 144.337, 143.985, 143.131, 133.228, 128.717, 128.680, 126.756, 126.681 (two overlapped peak), 126.068, 123.022, 122.979. Anal. Calcd for 3 (C15H11I2HgN3O): C, 25.60; H, 1.58; N, 5.97. Found: C, 25.49; H, 1.62; N, 5.90. IR (CsI pellet, cm-1): 3336s, 3058, 1677, 1552, 1500s, 1409s, 1019s, 794s, 775s. 1H NMR (DMSO, \u03b4 from TMS): 9.3916(s, 1H), 8.8838(d, 1H), 8.8264(d, 1H), 8.0323(m,1H), 7.9387(m,2H), 7.8347(m, 1H), 7.5504(m, 3H). 13C NMR (DMSO, \u03b4 from TMS): 162.715 (C\ue5fbO), 148.193, 145.305, 144.318, 143.981, 143.121, 133.206, 128.689, 128.669, 126.731, 126.694 (two overlapped peak), 126.080, 122.940 (two overlapped peak).", "data": [{"meta": {"name": "[HgCl2(L1)2]", "symbol": "1", "chemical formula": "C30H22Cl2HgN6O2"}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "HgCl2", "amount": "0.2", "unit": "mmol"}, {"name": "L1", "amount": "0.2", "unit": "mmol"}], "solution": [{"name": "methanol", "amount": "5", "unit": "mL"}], "pressure": "", "temperature": "313 K", "time": "10 min"}, {"synthesis method": "filtration", "filtration solution": "methanol", "amount": ""}, {"synthesis method": "evaporation", "evaporation solution": "filtrate", "amount": ""}], "yield": "ca. 63%"}, {"meta": {"name": "[HgBr2(L1)]", "symbol": "2", "chemical formula": "C30H22Br4Hg2N6O2"}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "HgBr2", "amount": "0.2", "unit": "mmol"}, {"name": "L1", "amount": "0.2", "unit": "mmol"}], "solution": [{"name": "methanol", "amount": "5", "unit": "mL"}], "pressure": "", "temperature": "313 K", "time": "10 min"}, {"synthesis method": "filtration", "filtration solution": "methanol", "amount": ""}, {"synthesis method": "evaporation", "evaporation solution": "filtrate", "amount": ""}], "yield": "50%"}, {"meta": {"name": "[HgI2(L1)]", "symbol": "3", "chemical formula": "C15H11I2HgN3O"}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "HgI2", "amount": "0.2", "unit": "mmol"}, {"name": "L1", "amount": "0.2", "unit": "mmol"}], "solution": [{"name": "methanol", "amount": "5", "unit": "mL"}], "pressure": "", "temperature": "313 K", "time": "10 min"}, {"synthesis method": "filtration", "filtration solution": "methanol", "amount": ""}, {"synthesis method": "evaporation", "evaporation solution": "filtrate", "amount": ""}], "yield": "55%"}], "include_properties": ["chemical_synthesis", "filtration"]}]